SIONNA THERAPEUTICS, INC. Stock Issued During Period, Shares, Conversion of Convertible Securities
SIONNA THERAPEUTICS, INC. (SION) had Stock Issued During Period, Shares, Conversion of Convertible Securities of 27.15 million shares as of 2025-01-31, per its 10-K filed 2026-03-02.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities · last filed 2026-03-02
- 2025-01-31: Stock Issued During Period, Shares, Conversion of Convertible Securities 27.15M shares.
| Period end | Stock Issued During Period, Shares, Conversion of Convertible Securities |
|---|---|
| 2025-01-31 | 27.15M shares 10-K · filed 2026-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |